Streetwise Reports' Article Archives — August 2019 back to current month (137)
The company's revised estimates, the reasons for and repercussions of them are addressed in a CIBC report.
Through recent work, the company determined the best methods for its requisite lithium recovery, concentration and leaching processes.
Campbell Soup Earnings Are Good Food for Investors (08/30/2019)
Now serving much more than just soup, shares of multi-brand food conglomerate Campbell Soup Co. are trading 10% higher today as the firm announced better than expected annual earnings.
The Critical Investor details the exploration of a joint ventured copper deposit in Saskatchewan.
This small-cap firm saw rapid growth and reported a record second quarter.
Observations and takeaways from a visit to the company's Bulgaria properties are given in a Haywood report.
The purpose of the work is to build a high-grade resource there.
This business is yet another addition to the company's growing list of software as a service customers.
The focus of both programs is a single zone at the gold property.
This is a significant development for the Colorado-based explorer.
Drilling in the first two vein zones continues to encounter high-grade gold.
Peter Epstein of Epstein Research does the math and reviews the details of an expected joint venture and the lithium market overall, and determines this company will benefit from the upsides.
Shares of global industrial packaging manufacturer Greif Inc. are trading 14% higher today after the company announced Q3/19 earnings.
Optical Development Company Revamps Binoculars (08/28/2019)
The Canadian firm makes a handful of alterations to the product.
Shares of Lannett Co. are up 40% today after announcing that it secured rights to be the exclusive U.S. distributor of Sinotherapeutics' antifungal drug that is an AB-rated generic for Noxafil.
Ross Beaty-Funded Explorer Makes Gold Discovery (08/28/2019)
In this interview with Bill Powers of Mining Stock Education, Osino Resources CEO and cofounder Heye Daun discusses the company's recently announced gold discovery, explains the significance of the initial diamond drill core results and shares how Osino Resources plans to continue to advance the project to maximize shareholder value.
Bad Moon Rising (08/28/2019)
Precious metals expert Michael Ballanger discusses trends in the market and his recent trades.
The drug's features and its developer's commercial plans are discussed in an H.C. Wainwright & Co. report.
A disconnect surrounding the company's EBITDA multiple is discussed in a Raymond James report.
Details from this clinical program are discussed, along with Q2/19 earnings and the next stock catalyst, in an H.C. Wainwright & Co. report.
Accomplishments and revised estimates are reviewed in a ROTH Capital Partners report.
An update on the Canadian company, including its Q2/19 results and its next expected catalyst, is provided in a Haywood report.
Standex Shares Trade Up 26% on Q4 Earnings (08/27/2019)
Shares of diversified manufacturer Standex International are trading 24% higher today after the company reported Q4/19 earnings.
Investors responded favorably to this footwear stock's Q2/19 results, elevating the stock price 24% on Tuesday. However, the stock is still down quite a bit from its 6-month and 1-year highs.
Sector expert and money manager Adrian Day discusses resource firms that he covers, including two major producers, one royalty company and one exploration company.
This morning PDC Energy announced that it will acquire SRC Energy in an all-stock deal valued at $1.7 billion. Shares of both companies are trading higher today on the merger news.
Demand for the Canadian company's product is growing in the Asia-Pacific region.
The program is key in identifying high-priority targets for a 2020 drill program.
The property features an extensive system of high-grade, gold- and silver-rich quartz veins and breccias.
The company's move marks an internal shift toward sales and trading of the element.
The market sold off on news from this junior miner operating in British Columbia's Golden Triangle, and Peter Epstein of Epstein Research questions the logic.
Why Provention Bio Is in My Portfolio (08/23/2019)
Orphan drug and breakthrough therapy status, which could mean this company's lead candidate is on the FDA fast track, translates to huge opportunities for both those suffering from diabetes and investors, says Daniel Carlson of Tailwinds Research.
Foot Locker Inc. shares set a 52-week intraday low after the firm reported Q2/19 earnings. The firm's shares are trading down more than 18% compounded by a day of market worries from China tariffs escalation.
Shares of Retrophin fell to a 52-week low on the news that topline results from its fosmetpantotenate Phase 3 FORT Study for PKNA treatment failed to meet expectations.
The initiative, to start in Calgary, is expected to expand rapidly into other cities.
Novo Scores +1 Gram Per Meter at Egina (08/22/2019)
Bob Moriarty of 321 Gold comments on the bulk sample assays from the company's Egina project in Australia.
The investment thesis on this Canadian company is delivered in a BMO Capital Markets report.
All holes drilled this season at the company's Golden Triangle project intersected polymetallic mineralization.
The company expects the initial set of results to become available in the near term.
A new agreement outlines the obligation to exercise the option.
The country represents a significant market for feed consumption.
Peter Epstein of Epstein Research compares this explorer to others in the area.
The exploration company intends to follow up on these initial results.
Increased production in Thailand drove the quarter-over-quarter revenue boost.
The company reported the latest results from its in-progress drill program.
Goliath Drills a 718-Meter Porphyry (08/21/2019)
Bob Moriarty of 321 Gold provides an update on recent exploration developments at this company's project located in British Columbia's Golden Triangle.
One year following its IPO, Chinese mobile and internet e-commerce platform company Pinduoduo Inc. reported 169% revenue growth and an 88% growth in monthly active users.
The next steps for each of the programs are outlined in a Dawson James Securities report.
Resource Maven Gwen Preston describes how leadership and a promising project in British Columbia translates to a compelling option for investors.
Explorer to Sell Nevada Mine to McEwen Mining (08/20/2019)
The deal provides the seller with financial flexibility.
Dublin-based Medtronic reported Q1/20 earnings and revised its full-year earnings outlook upward sending shares up more than 5% today.
A Potential CBD Processor with 'Blue-Sky Prospects' (08/20/2019)
Peter Epstein of Epstein Research speaks with Martin Doane, CEO of Leviathan Cannabis Group, about the company's international plans to grow hemp and produce a hemp-derived CBD isolate and what sets the company apart from its peers.
The combined, diversified company states it intends to aggressively grow its portfolio.
A Summer Epiphany: Carpe Sanctum (08/20/2019)
Sector expert Michael Ballanger compares safe harbor on the water to safe harbor in the financial and precious metals markets.
Adrian Day: Stay with the Royalties in a Bull Market (08/20/2019)
Money manager Adrian Day explains why he is a believer in holding royalty company shares in a bull market.
Cashed-Up Explorer Set to Drill Gold-Copper Porphyry (08/20/2019)
James Kwantes of Resource Opportunities profiles an explorer with projects in British Columbia and Chile.
Blackrock Swings for the Fences at Silver Cloud (08/19/2019)
Bob Moriarty of 321 Gold discusses this company's exploration efforts at its Nevada gold project.
Bob Moriarty of 321 Gold explains why he believes the financial outlook is dismal and discusses a handful of resource companies that are on his radar.
Weibo Corp. shares are trading 15% higher today after the firm announced that it increased year-over-year monthly and daily active users to 486 million and 211 million, respectively.
Millennial Lithium CEO Farhad Abasov speaks with Peter Epstein of Epstein Research about his company's just released bank feasibility study.
The metallurgical result and its implications are addressed in a ROTH Capital Partners report.
The rationale for investing in this Canadian mining company is given in this BMO Capital Markets report.
This event, its implications and near-term catalysts are discussed in a Pareto Securities report.
After combining the two solutions, the resulting product will be rolled out to existing U.S. clients.
The Canadian company is testing for the presence of Getchell-style, high-grade gold there.
The results highlight the potential for the explorer to grow its mineral inventory.
The State of the Financial Union (08/16/2019)
Bob Moriarty of 321 Gold makes available the first two chapters of his most recent book that delve into the current state of the economy.
Solid Biosciences' shares are up by more than 40% today after Chardan Capital Markets upgraded the firm's shares from "neutral" to "buy" and raised its price target from $7.50 to $10.00/share.
Exploring for Gold in Labrador (08/16/2019)
Roger Moss, CEO of Labrador Gold, sits down with Maurice Jackson of Proven and Probable to discuss his company's exploration efforts in Labrador.
A Mackie Research Capital Corp. report provided the reasons why the cheap price of this company's stock is unwarranted.
An update on this company's valuation is provided in a Raymond James report.
Further upside potential remains deeper in the gold system.
A Canadian explorer concluded this based on recent and historical exploration work there.
This company is disrupting the recruiting industry by using advanced technology, such as artificial intelligence, to connect employers to its wide network of over 10,000 independent recruiters.
Canadian Solar, which operates a portfolio of utility-scale solar operated power plants, reported higher Q2 earnings.
Through their collaborative efforts, both companies aim to target the cannabis industry.
Positive results to date prompted this decision.
Both Israeli companies are working together to increase the number of visitors to their country.
One of the partners provided an update on that project and another one in Indonesia.
Shareholders of Gold Royalty Company Approve Merger (08/14/2019)
The plan of agreement is slated to go into effect around Aug. 19.
InMode Ltd. reported Q2/19 earnings and announced that international pop superstar Paula Abdul will be its brand ambassador sending shares "Straight Up" 15% as investors "Rush Rush" to purchase shares today.
Nick Appleyard, CEO of TriStar Gold, talks with Maurice Jackson of Proven and Probable about advancing his company's gold project in Brazil.
Peter Epstein profiles recent developments with this company that has a large vanadium deposit in Nevada, with a PEA on the way.
The company aims to better delineate and potentially expand the deposit.
One of the partners provides a project update.
Deciphera Pharmaceuticals announced positive top-line results from the INVICTUS pivotal phase 3 clinical study of ripretinib in patients with advanced gastrointestinal stromal tumors.
The pros and cons of the parameters outlined within it were addressed in a ROTH Capital Partners report.
The latest development concerning this clinical asset and other Q2/19 highlights are provided in an H.C. Wainwright & Co. report.
The terms of the financing package and the company's plans for the rest of 2019 are described in an Echelon Wealth Partners report.
Senior Gold Miner Is On Track for a 'Strong H2/19' (08/12/2019)
The company's Q2/19 operational and financial results are reviewed in a BMO Capital Partners report.
Amgen shares are trading 5–6% higher today on news that the company has won its Enbrel (etanercept) patent court case.
Invasive Species (08/12/2019)
Sector expert Michael Ballanger draws connections between nefarious non-native species in the natural world and in the world markets.
The move should expand awareness of and increase investment opportunities for the company.
Selling third party applications is one source of revenue for the Canadian company.
Previous exploration work, including a phase one drill campaign earlier this year, confirmed the prospectivity there.
Shares in Puma Biotechnology are trading 20% higher today after the company released Q2/19 earnings and reported positive NERLYNX revenue growth.
Atomera: When Will Revenues Start? (08/09/2019)
Daniel Carlson of Tailwinds Research delves into the company's earnings report.
Daniel Carlson of Tailwinds Research digs into the issues and potential of this company, which received an infusion of cash from a major Japanese manufacturer.
These new assets expand the Canadian company's prospective project portfolio there.
Pit Wall Fails at Burkina Faso Mine (08/08/2019)
The company will suspend ore processing there while it remedies the situation.
The new assays are comparable to those from previous samples taken from the historical district property.
Mickey Fulp, the Mercenary Geologist, and Maurice Jackson of Proven and Probable discuss the resurgent precious metals markets, as well as base metals, critical metals and energy metals.
Gold Is Due a Correction (08/08/2019)
Bob Moriarty of 321 Gold gives his outlook on the gold market.
Avedro Shares Looking Up 35% with Glaukos Merger (08/08/2019)
Avedro Inc. and Glaukos Corp. announced that the firms' boards of directors have executed a definitive merger agreement. The all-stock deal is expected to close in Q4/19.
The latest drill results are delivered and interpreted in an iA Securities report.
Technical analyst Clive Maund describes how the takeover deal has and will affect stock prices for both companies.
Gold Firm Inaugurates New Assay Laboratory in Fiji (08/07/2019)
The facility will support the company's existing gold project there and its exploration efforts nearby.
Guardant Health Reports Quarterly Revenue Up 178% (08/07/2019)
Guardant Health Inc. reported strong growth for Q2/19 versus the same period last year and raised its full-year 2019 revenue guidance to $180–190 million.
A review of the firm's quarterly operational and financial results is given in a Raymond James report.
Drone Data Company Changes Ticker Symbol Post Merger (08/06/2019)
When done, the firm will have finished its corporate transition.
Shares of WPX Energy are trading higher after it released second quarter earnings and raised full-year oil guidance by 4%. The firm also announced it is initiating a 24-month, $400 million share repurchase program.
These results are from an ongoing mapping and sampling program at various levels of the underground workings.
The company closes a first tranche of a private placement for proceeds of approximately CA$1.5 million.
Although assays are pending, the company states the visual indicators are encouraging.
The company notes that this year's drilling program re-emphasizes high potential exploration drilling on targets that can drive the project's valuation.
We Should Let the Banks Burn Down (08/05/2019)
Bob Moriarty of 321 Gold explains why he believes banks should be allowed to fail.
'Once in a Blue Moon' Short/Put Set Up (08/05/2019)
Technical analyst Clive Maund charted the S&P 500 and saw a "perfect shorting set-up."
Miner Sees Potential in Historical Canadian Site (08/05/2019)
In an interview with Maurice Jackson of Proven and Probable, executives from this prospect generator exploring in Ontario outline their work on a new project.
Allakos Inc. shares are soaring today as the company reported Q2/19 earnings and announced positive results from its phase 2 study for its AK002 inhibitor used in the treatment of eosinophil and mast cell related diseases.
Hitting bonanza grades during a gold bull means good things for investors.
MLP Achieves 'Another Beat and Raise' in Q2/19 (08/04/2019)
Performance during the quarter and guidance for the rest of 2019 are reviewed in a Raymond James report.
Key Q2/19 financial metrics and upcoming catalysts are covered in a ROTH Capital Partners report.
Peter Epstein of Epstein Research interviews Drone Delivery Canada's new CEO Michael Zahra, who describes how he is commercializing the company's technology platform.
Thibaut Lepouttre of the Caesar’s Report has combed through the data, done the math and provides this assessment on the mining firm.
The highlights of the quarterly update are presented in an iA Securities report.
The company's latest science, presented at a recent conference, is discussed in a ROTH Capital Partners report.
Biotech's Mosquito Test 'Gains Market Acceptance' (08/02/2019)
This West Nile virus test and others including cancer diagnostic tests in the Utah company's pipeline are discussed in an H.C. Wainwright & Co. report.
Permits have been obtained and a drilling company engaged.
Results from those activities, which are pending, will inform additional drilling.
Tandem Diabetes Care's second quarter earnings highlighted a 290% increase in unit sales of its t:slim X2 insulin pumps that feature integrated continuous glucose monitoring and remote software update capability.
The initial goal is to enhance the one firm's existing security products through the use of artificial intelligence technology.
Recent drill results prompted mobilizing a second rig to boost exploration efforts.
Based on the results, this Canadian company will continue advancing this project in Idaho.
Recent results include the best drill intercepts there to date.
Production, costs, guidance and financials of this miner are reviewed in this CIBC report.
Gaia Grow Corp. CEO Frederick Pels speaks with Peter Epstein of Epstein Research on the day his company begins trading on the TSX Venture Exchange.
Shares of Vanda Pharmaceuticals traded nearly 30% higher after the company released Q2/19 earnings and positive sales trends for both HETLIOZ and Fanapt.
|"NTAR's business is still growing well on the e-commerce and AR sides."|
|"We came away from a site visit to LIO's Tuvatu very impressed."|
|"TRCH debt holders converted the obligations into a working interest."|
|"We are initiating coverage on ELY with an Outperform rating."|
|"The drills are still turning, and GBR has plenty of cash."|